{
 "drug": "Insulin Glargine-aglr Injection",
 "asOf": "2026-10-09",
 "status": "discontinuing",
 "since": "09/01/2026",
 "dayN": 38,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "Eli Lilly and Co."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/01/2026",
   "update_type": "New",
   "initial_posting_date": "09/01/2026",
   "package_ndc": "0002-8980-05",
   "generic_name": "Insulin Glargine-aglr Injection",
   "contact_info": "800-545-5979",
   "related_info": "A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.",
   "openfda": {
    "application_number": [
     "BLA761215"
    ],
    "brand_name": [
     "REZVOGLAR KWIKPEN"
    ],
    "generic_name": [
     "INSULIN GLARGINE-AGLR"
    ],
    "manufacturer_name": [
     "Eli Lilly and Company"
    ],
    "product_ndc": [
     "0002-8980"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "INSULIN GLARGINE"
    ],
    "rxcui": [
     "2589008",
     "2589014"
    ],
    "spl_id": [
     "a9e95b4c-e280-4bef-a3dd-4907bfad6b4d"
    ],
    "spl_set_id": [
     "f6af8706-2058-4fe1-99c8-43684c20bfa2"
    ],
    "package_ndc": [
     "0002-8980-01",
     "0002-8980-05"
    ],
    "nui": [
     "M0011417",
     "N0000175453"
    ],
    "pharm_class_cs": [
     "Insulin [CS]"
    ],
    "pharm_class_epc": [
     "Insulin Analog [EPC]"
    ],
    "unii": [
     "2ZM8CX04RZ"
    ]
   },
   "update_date": "09/01/2026",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Injection",
   "presentation": "Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  }
 ],
 "firstSeen": "2026-09-03",
 "history": [
  {
   "date": "2026-09-03",
   "kind": "new",
   "to": "discontinuing",
   "text": "Insulin Glargine-aglr Injection appeared on the FDA shortage list (being discontinued)"
  }
 ]
}